Quick Summary
Medication for opioid use disorder, sometimes called MAT or MOUD, dramatically improves recovery outcomes. Research summarized by SAMHSA and the National Institute on Drug Abuse shows that people taking methadone or buprenorphine are roughly half as likely to die of overdose compared to those not receiving medication, and they stay in treatment longer. This guide walks through what the evidence actually shows about why MAT changes outcomes.
Key Takeaways
- Methadone has been associated with about a 59 percent reduction in opioid-related deaths compared to no medication treatment.
- Buprenorphine has been associated with about a 38 percent reduction in opioid-related deaths.
- Treatment retention with MAT is significantly higher than detox-only or counseling-only approaches.
- MAT works best when combined with counseling, peer recovery support, and treatment for co-occurring conditions.
- The choice of medication is individualized, made between a person and a qualified prescriber.
The phrase “MAT nearly doubles your chances of recovery” is shorthand for a much larger evidence base. Research published by the Substance Abuse and Mental Health Services Administration and the National Institute on Drug Abuse consistently shows that FDA-approved medications change outcomes for people with opioid use disorder in ways no other intervention has matched. This article walks through what the evidence actually shows.
The Headline Numbers
People with opioid use disorder who take prescribed methadone or buprenorphine are roughly 50 percent less likely to die of overdose than those receiving no medication (Sordo et al., 2017). In one large observational study of people who had survived an overdose, methadone was associated with about a 59 percent reduction in opioid-related deaths and buprenorphine with about a 38 percent reduction, each compared with receiving no medication (Larochelle et al., 2018). Because each medication was compared with no treatment rather than with the other, these figures should not be read as proof that one medication is better than the other; both substantially reduce overdose death. These are not small effects.
Why MAT Works
Opioid use disorder is a chronic brain condition. The medications used in MAT work directly on the biology of that condition.
- Methadone and buprenorphine reduce cravings and withdrawal symptoms by activating opioid receptors at a steady, controlled level. The brain stops being in constant withdrawal-and-recovery cycles. The cognitive bandwidth that was consumed by managing cravings becomes available for therapy, relationships, work, and life.
- Naltrexone blocks opioid receptors entirely, so opioids cannot produce a high. Its main challenge is getting started, because a person must be fully off opioids before the first dose; once successfully started, extended-release naltrexone was about as effective as buprenorphine-naloxone at preventing relapse in the X:BOT trial.
Why Retention Matters
The single best predictor of recovery from opioid use disorder is staying in treatment. MAT medications keep people in treatment longer than detox-only or counseling-only approaches. The longer the treatment, the better the outcomes across nearly every measure: reduced use, reduced criminal activity, improved health, improved employment, improved relationships.
We’re here to make treatment as accessible and affordable as possible — and are in network with many insurance providers. Not sure about your coverage? We can help.
MAT Plus Counseling
Medication is one component. The best outcomes come from combining MAT with counseling (individual or group), peer recovery support, treatment for any co-occurring mental health conditions, and coordination of physical health care. The medication creates the stability that allows the other work to happen.
Common Misconceptions
“MAT is replacing one drug with another.” Methadone and buprenorphine activate opioid receptors but do so in a controlled, sustained way that stabilizes brain chemistry rather than producing the chaos of illicit opioid use. This is treatment, not substitution in any harmful sense.
“You have to be on MAT forever.” Length of treatment is individualized. Some people use medications for months, others for years, others indefinitely. Decisions are made between a person and their prescriber based on stability, risks, and goals.
The FDA-Approved Medications
The FDA Medications for Opioid Use Disorder page covers prescribing information for methadone, buprenorphine (Suboxone, Subutex), and naltrexone (Vivitrol, oral naltrexone). All three are evidence-based and safe when prescribed appropriately. The right choice depends on the individual’s history, preferences, and clinical situation.
Talking With a Professional
If you or someone you love is considering MAT, the next step is a conversation with a qualified clinician. They can run an assessment, talk through which medication may fit best, and explain what counseling and support will look like alongside it. The admissions team at Discovery Point Retreat can help you understand what an assessment involves and what options exist.
References
- Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137-145. NIH summary.
- Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. Full text.
- Lee JD, Nunes EV, Novo P, et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT). Lancet. 2018;391(10118):309-318. Full text.
- National Institute on Drug Abuse. Medications to treat opioid use disorder. Accessed June 8, 2026. nida.nih.gov.
- Substance Abuse and Mental Health Services Administration. Co-occurring disorders and treatment. Accessed June 8, 2026. samhsa.gov.
Resources
- 988 Suicide and Crisis Lifeline. Call or text 988, or chat at 988lifeline.org. Free, confidential support 24/7.
- SAMHSA National Helpline. Call 1-800-662-HELP (4357) or visit the SAMHSA National Helpline page for free, confidential referrals to local treatment.
- 911. For any medical emergency, including suspected overdose, call 911 immediately. If naloxone is available for a suspected opioid overdose, administer it according to the package instructions while waiting for help.
This article is general education and is not medical advice. It does not establish a clinician-patient relationship and is not a substitute for an individual assessment by a qualified mental health or addiction treatment professional.
